Margaret Wecker

Efficacy of Tremacamra, a Soluble Intercellular Adhesion Molecule 1, for Experimental Rhinovirus Infection

Ronald B. Turner, Margaret Wecker, Gerhardt Pohl et al. · JAMA · 1999 · 202 citations

Phase I Safety and Immunogenicity Evaluations of an Alphavirus Replicon HIV-1 Subtype C<i>gag</i>Vaccine in Healthy HIV-1-Uninfected Adults

Margaret Wecker, Peter B. Gilbert, Nina D. Russell et al. · Clinical and Vaccine Immunology · 2012 · 67 citations · Full text

Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults

Geoffrey J. Gorse, Lindsey R. Baden, Margaret Wecker et al. · Vaccine · 2007 · 58 citations

Vaccination, Ep Hiv-1090, Vaccine Target +8

A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold

Louis S. Diamond, Robert J. Dockhorn, Jay Grossman et al. · Journal of Allergy and Clinical Immunology · 1995 · 55 citations

Asthma, Common Cold, Allergy Medicine +6

Product characteristics and pharmacokinetics of intranasal ipratropium bromide

Catherine L. Wood, Philip Fireman, Jay Grossman et al. · Journal of Allergy and Clinical Immunology · 1995 · 50 citations

Pharmacological Study, Intranasal Ipratropium Bromide, Medicine +3